Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer

NCT07166185 · clinicaltrials.gov ↗
RECRUITING
Status
70
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Blida 1 University